Cidara Therapeutics (CDTX) 2025 Conference Transcript
2025-05-07 16:00
Cidara Therapeutics (CDTX) 2025 Conference May 07, 2025 11:00 AM ET Speaker0 Alright. Thank you everybody again for joining us, Citizens Life Science Conference here. We, next company we have is Sadara Therapeutics, and we have Jeff Stein is president and CEO and a co founder. Frank Carbe, CFO, was going to be here, had some travel related issues, but we're happy to have Jeff here to walk us through the Sadara story. Pretty exciting few weeks coming up definitely with a phase two b breed out at the June. So ...
UFG(UFCS) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:00
United Fire Group (UFCS) Q1 2025 Earnings Call May 07, 2025 11:00 AM ET Speaker0 day, and welcome to the United Fire Group Insurance twenty twenty five First Quarter Conference Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Tim Borst, Investor Relations. Please go ahead. Speaker1 Good morning, and thank you for joining this call. Yesterday ...
Mammoth Energy Services(TUSK) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:00
Mammoth Energy Services (TUSK) Q1 2025 Earnings Call May 07, 2025 11:00 AM ET Speaker0 a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Zach Phong. Thank you. You may begin. Speaker1 Thank you, operator, and good morning, everyone. We appreciate you joining us for the Mammoth Energy conference call to review twenty twenty five first quarter results. This call is also being webcast and can be accessed through the audio link on the Events and Presentations page of t ...
Prelude Therapeutics (PRLD) 2025 Conference Transcript
2025-05-07 16:00
Prelude Therapeutics (PRLD) 2025 Conference May 07, 2025 11:00 AM ET Speaker0 I've been working on it for a awhile but now we have two molecules, one an IV and one an oral agent, both in the clinic that are targeting a very unique pathway called SMARK pathway, desired SMARK2 degraders, and there is a high unmet need in patients who have this mutation since SMARK4, a related family member that results in pretty aggressive cancers across multiple cancer types. So we've made a lot of progress. We demonstrated ...
Granite Point Mortgage Trust(GPMT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 16:00
Granite Point Mortgage Trust (GPMT) Q1 2025 Earnings Call May 07, 2025 11:00 AM ET Speaker0 Good morning. My name is Paul, and I will be your conference facilitator. At this time, I would like to welcome everyone to Granite Point Mortgage Trust First Quarter twenty twenty five Financial Results Conference Call. All participants will be in a listen only mode. After the speakers' remarks, there will be a question and answer period. Please note, today's call is being recorded. I would now like to turn the call ...
TripAdvisor(TRIP) - 2025 Q1 - Earnings Call Presentation
2025-05-07 15:56
Q1 FY 2025 Investor Presentation May 2025 Tripadvisor Safe Harbor Statement Forward-Looking Statements. Our presentation today, including the slides contained herein, contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not historical facts or guarantees of future performance and are based on management's assumptions and expectations, which are inherently subject to difficult to predict uncertainties, risks and changes in circ ...
Astria Therapeutics (ATXS) 2025 Conference Transcript
2025-05-07 15:30
Astria Therapeutics (ATXS) 2025 Conference May 07, 2025 10:30 AM ET Speaker0 Morning, everybody, and welcome to day one of the Citizens Life Science Conference. My name is John Wallabin, senior analyst here. We're pleased to have Astria Therapeutics and CEO, Jill Millney, joining us today. Astria is a company we launched coverage on, I think, earlier this year in January. We've been covering the hereditary angioedema space for quite some time, and I think this is one of the more compelling pipeline candidat ...
Marcus & Millichap(MMI) - 2025 Q1 - Earnings Call Transcript
2025-05-07 15:30
Marcus & Millichap (MMI) Q1 2025 Earnings Call May 07, 2025 10:30 AM ET Speaker0 Greetings, and welcome to Marcus and Millichap's first quarter twenty twenty five earnings conference call. As a reminder, this call is being recorded. I would now like to turn the conference over to your host, Yac Korne. Thank you. You may begin. Speaker1 Thank you, operator. Good morning, and welcome to Marcus and Millichap's First Quarter twenty twenty five Earnings Conference Call. With us today are President and Chief Exec ...
McGrath RentCorp (MGRC) FY Conference Transcript
2025-05-07 15:30
McGrath RentCorp (MGRC) FY Conference May 07, 2025 10:30 AM ET Speaker0 Hey. Good morning, everyone. I'm Scott Schneeberger, senior business and industrial services analyst at Oppenheimer. Thank you all for joining us today. It's my pleasure to have from McGrath, with us today, the CFO, of excuse me. The CEO, Johanna, the CFO, Keith Pratt, and the COO, Phil Hawkins. We look forward to hearing the story. McGrath rents and sells modular office and classrooms and portable storage containers and electronic test ...
Snap-on (SNA) FY Conference Transcript
2025-05-07 15:30
Snap-on (SNA) FY Conference May 07, 2025 10:30 AM ET Speaker0 Thank you, Annie, and welcome everyone to our Generac fireside session. Special thanks to Nick Aldo and Sarah for joining from Generac and glad to have you guys back at the conference. Thanks for participating. So I think wanted to kick off with sort of a high level kind of frame up type question then get into some of the comings and goings of the business model and the market backdrops. But Nick, maybe if you could discuss Snap on's market posit ...